YOU ARE HERE: LAT HomeCollectionsResearch


May 1, 1989 | From Times staff and wire reports
American science is missing "superb opportunities," the head of the National Academy of Sciences said last week, calling for federal research support to double to $20 billion during the next five years. In a speech at the group's annual meeting, Frank Press called on the government to "double federal investments in basic science over five years for all agencies with science in their missions." Currently, about $10.2 billion is allocated for such work.
April 6, 2014
The company: Acacia Research Corp. Headquarters: Newport Beach Ticker: ACTG Employees: 68 Leadership: Matthew Vella, 42, chief executive since 2013 2013 revenue: $130.6 million 2013 net loss: $56.4 million Stock price: $17.19 at Friday's close 52-week range: $12.23 to $30.36 Quarterly dividend: 12.5 cents a share, a current yield of 2.9%
November 15, 2008 | Times Wire Services
Pfizer Inc. said it had launched a biotechnology research unit focused on developing stem-cell-based treatments for a wide range of conditions. The unit, called Pfizer Regenerative Medicine, will be located in two of the global hubs for biotech research -- Cambridge, England, and Cambridge, Mass. New York-based Pfizer plans to invest about $100 million in the project over the next three to five years.
April 6, 2014 | By Jen Leo
Here's the latest trip-planning website that can help you craft your own guidebook. Name: What it does: It's a Web bookmarking tool that lets you collect and store your travel itineraries, complete with maps and the ability to download and share. Cost: Free What's hot: This website has two things that will keep me coming back: its beautiful, design-friendly layout, and the ability to print out a PDF of my itinerary. I love being able to access my travel plans from my smartphone or tablet, as well as sharing with my friends on Facebook, Twitter and Pinterest, but I'm still a paper girl at heart.
J. D. Power & Associates in Agoura Hills is nearly synonymous with car research, which Power has earned by publishing customer-satisfaction surveys and other analyses for the world's auto makers for more than a decade. But that isn't stopping AutoPacific Group Inc. of Santa Ana from trying to muscle in on parts of Power's business.
Conditions are nearly ideal as John Fales heads briskly out the front door with his butterfly net and a worn green canvas bag slung over his shoulder. It's 75 degrees on a mostly sunny afternoon in the early fall. A gentle breeze ripples the waters of Chesapeake Bay, a short walk from Fales' home at Plum Point in Calvert County, Md. Fales records the temperature from a gauge atop a pole in his yard and writes down the time. Ready now, he scans the shrubs in his yard and the sky overhead.
Michael Verhoeven's film "The Nasty Girl" is Germany's entry in the foreign-language category in this year's Academy Awards. It is an occasionally surrealistic and often very funny account of a teen-aged Fraulein's distinctly unfunny and dangerous attempts to investigate the Nazi years in her hometown.
February 11, 2008 | By Regina Nuzzo, Special to The Times
AS they seek to document and demystify one of life's great thrills, scientists have run across some real head-scratchers. How, for example, can they explain the fact that some men and women who are paralyzed and numb below the waist are able to have orgasms? How to explain the "orgasmic auras" that can descend at the onset of epileptic seizures -- sensations so pleasurable they prompt some patients to refuse antiseizure medication? And how on Earth to explain the case of the amputee who felt his orgasms centered in that missing foot?
July 20, 2010 | By Shari Roan, Los Angeles Times
You can't say Alzheimer's researchers aren't trying really hard to make progress in preventing and treating the disease. A team of researchers is cycling across the country to raise awareness of the need for more funding for the study of Alzheimer's. The Alzheimer's Breakthrough Ride will pass through Los Angeles on Thursday. Members of the Alzheimer's Assn.'s California Southland Chapter will meet from 11 a.m. to 2 p.m. in front of the Kodak Theatre, at the corner of Hollywood and Highland, to cheer on the riders.
July 26, 2011 | By Marissa Cevallos, HealthKey / For the Booster Shots blog
Some of the richest countries have the highest rates of depression, new research suggests. An international team of researchers collected the results of face-to-face interviews of nearly 90,000 people considered representatives of their population. The interviews were conducted in community settings in 18 countries, and the interviewers used a standard diagnostic test from the World Health Organization to assess depression. In the 10 countries considered high-income, an average of 15% of participants said they'd experienced a depressive episode in their lifetime.
April 6, 2014 | By Ronald D. White
Matthew Vella certainly doesn't look like a troll. Vella is the regular-guy chief executive of Acacia Research Corp., which calls itself a patent outsource licensing company. The Newport Beach firm links up with inventors who fear that others are elbowing in on their patents or whose patents aren't making the money they could. "Our clients often can't afford to hire specialists that will help turn those patents into money," Vella said. "They are not looking to sell them necessarily, but if they are looking to get money because people are infringing their patents, we want to be their partner.
March 28, 2014 | By Howard Blume
David Koff, a filmmaker and union activist whose investigation of a campus construction project profoundly changed the Los Angeles school system, has died. He was 74. He committed suicide March 6 in Hastings, N.Y., his family said. Koff was the indefatigable researcher who, in the 1990s, took on the Belmont Learning Complex, turning it into a symbol of civic dysfunction as it became the nation's most expensive high school. Outside Los Angeles, Koff was best known as a talented documentary filmmaker who took uncompromising stands.
March 19, 2014 | By The Times editorial board
Alzheimer's disease and other dementias not only destroy the lives of those who suffer from them but take a devastating toll on family caregivers and on those who must pay the cost of care. An estimated 5 million people in the United States suffer from Alzheimer's. But that number will increase exponentially in the years ahead because of what Robin Barr, a senior official at the National Institute on Aging, calls "an aging tsunami. " A highly cited published research analysis estimates that the number of people with Alzheimer's around the world will jump from 36 million today to 115 million by 2050.
March 15, 2014 | By Alan Zarembo
It costs about $2,000 to buy an ounce of the illegal drug, the therapist said - enough for roughly 150 doses. She pays her longtime dealer in cash; he gives her a Ziploc bag of white powder. Back home, she scoops the contents into clear capsules. She calls it "the medicine"; others know it as MDMA, the active ingredient in the party drug Ecstasy. MDMA has been banned by the federal government since 1985 as a dangerous recreational drug with no medical value. But interest is rising in its potential to help people suffering from psychiatric or emotional problems.
March 14, 2014 | By Evan Halper and Cindy Carcamo
WASHINGTON - The Obama administration handed backers of medical marijuana a significant victory Friday, opening the way for a University of Arizona researcher to examine whether pot can help veterans cope with post-traumatic stress, a move that could lead to broader studies into potential benefits of the drug. For years, scientists who have wanted to study how marijuana might be used to treat illness say they have been stymied by resistance from federal drug officials. The Arizona study had long ago been sanctioned by the Food and Drug Administration, but under federal rules, such experiments can use marijuana only from a single, government-run farm in Mississippi.
March 14, 2014 | By Karen Kaplan and Monte Morin
The Japanese research institution at the center of a growing controversy over a new type of stem cells said Friday that its investigation of four scientists has confirmed two instances of "inappropriate" behavior but that neither case was severe enough to be considered intentional misconduct or outright fabrication of data. An investigative committee at RIKEN, which is funded primarily by the Japanese government, has been looking into charges that two high-profile papers published in January in the journal Nature included plagiarized material, duplicate photos and doctored figures.
February 6, 2014 | By Daniel Rothberg
WASHINGTON - The United States could be losing its edge in science and technology as emerging nations rapidly increase their investment in research and development, according to new indicators released Thursday by the National Science Board. Although the United States outspends all other nations at least 2 to 1, its share of global spending on R&D has fallen in the last decade. With China at the lead, Asia's major economies together now account for a larger share of scientific investment, the indicators show.
July 12, 2012 | By Timothy D. Wilson
Once, during a meeting at my university, a biologist mentioned that he was the only faculty member present from a science department. When I corrected him, noting that I was from the Department of Psychology, he waved his hand dismissively, as if I were a Little Leaguer telling a member of the New York Yankees that I too played baseball. There has long been snobbery in the sciences, with the "hard" ones (physics, chemistry, biology) considering themselves to be more legitimate than the "soft" ones ( psychology, sociology)
March 13, 2014 | By Hector Tobar
According to a new study released Thursday by the Pew Research Center, public libraries are thriving thanks to a core group of devotees who have qualities we don't usually associate with bookish people -- they are, generally speaking, more sociable and active people than those who don't go to libraries. The report , which surveyed more than 6,000 people over age 16, paints a somewhat surprising portrait of American library lovers. More than two-thirds of Americans are “actively engaged” with their public libraries.
March 12, 2014 | By Karen Kaplan
A project that could point the way to a new class of drugs to treat influenza won the top prize Tuesday night at the Intel Science Talent Search, netting 17-year-old Eric S. Chen a cool $100,000. Chen, a senior at Canyon Crest Academy in San Diego, combined chemistry, biology and computer modeling to find compounds capable of blocking an enzyme called endonuclease, which the flu virus needs to spread. Despite taking home the grand prize at the 2013 Google Science Fair and the top individual honor at the 2013 Siemens Competition in Math, Science and Technology , Chen said he didn't expect to come in first at the Intel competition . “I had no idea I was going to win,” Chen told his hometown newspaper, the San Diego Union-Tribune, after the awards were announced in Washington, D.C. “If I had placed between fifth and 10th, I would have been incredibly happy.” Chen has worked in the lab of Rommie Amaro , an assistant professor of chemistry and biochemistry at UC San Diego, since the summer of 2012.
Los Angeles Times Articles